Last reviewed · How we verify

NCT05136001

Characterizations of Gut Microbiota and Postoperative Sleep in Patients Undergoing Heart Valve Surgery With Cardiopulmonary Bypass

Completed Last updated 25 October 2022
What this trial tests

trial testing polysomnography in Heart Valve Surgery in 36 participants. Completed in 10 August 2022.

Timeline
8 November 2021
Primary endpoint
10 July 2022
10 August 2022

Quick facts

Lead sponsorChina Medical University, China
StatusCompleted
Study typeOBSERVATIONAL
Enrollment36
Start date8 November 2021
Primary completion10 July 2022
Estimated completion10 August 2022
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

China Medical University, China

Who can join

Adults 18 to 65, any sex, with Heart Valve Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators designed a study to assess whether there is any change in gut microbiota and postoperative sleep before and after heart valve surgery with cardiopulmonary bypass.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of polysomnography

Trials testing the same drug.

Other recruiting trials for Heart Valve Surgery

Currently open trials in the same condition.

Other China Medical University, China trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05136001.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing